Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Rifampicin-resistant Mycobacterium tuberculosis: an emerging threat to human health in Botswana
Thesis (PhD)--Stellenbosch University, 2026.
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Stellenbosch : Stellenbosch University
2026
|
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867614005864955904 |
|---|---|
| access_status_str | Open Access |
| author | Mogashoa, Tuelo |
| author2 | Streicher, Elizabeth Maria |
| author_browse | Mogashoa, Tuelo Streicher, Elizabeth Maria |
| author_facet | Streicher, Elizabeth Maria Mogashoa, Tuelo |
| author_sort | Mogashoa, Tuelo |
| collection | Thesis |
| dc_rights_str_mv | Stellenbosch University |
| description | Thesis (PhD)--Stellenbosch University, 2026. |
| format | Thesis |
| id | oai:scholar.sun.ac.za:10019.1/136183 |
| institution | Stellenbosch University (South Africa) |
| language | English |
| last_indexed | 2026-06-10T12:45:09.986Z |
| license_str | Other — see source repository |
| provenance_str_mv | Harvested via OAI-PMH from SUNScholar — Stellenbosch University Repository |
| publishDate | 2026 |
| publishDateRange | 2026 |
| publishDateSort | 2026 |
| publisher | Stellenbosch : Stellenbosch University |
| publisherStr | Stellenbosch : Stellenbosch University |
| record_format | dspace |
| source_str | SUNScholar — Stellenbosch University Repository |
| spelling | oai:scholar.sun.ac.za:10019.1/136183 Rifampicin-resistant Mycobacterium tuberculosis: an emerging threat to human health in Botswana Mogashoa, Tuelo Streicher, Elizabeth Maria Dippenaar, Anzaan Moyo, Sikhulile Gaseitsiwe, Simani Stellenbosch University. Faculty of Medicine and Health Sciences. Dept. of Biomedical Sciences. Division of Molecular Biology and Human Genetics. Thesis (PhD)--Stellenbosch University, 2026. Mogashoa, T. 2026. Rifampicin-resistant Mycobacterium tuberculosis: an emerging threat to human health in Botswana. Unpublished doctoral dissertation. Stellenbosch: Stellenbosch University [online]. Available: https://scholar.sun.ac.za/items/ad852578-9d9a-47f9-8e3a-799cf8b70a85 Rifampicin-resistant tuberculosis (RR-TB) continues to threaten global TB control. The World Health Organisation (WHO) estimated that 400,000 people developed RR-TB in 2023, with Africa being among the regions with the highest burden. Botswana, a high TB/HIV burden country, has reported an increase in RR-TB notifications in recent years; however, the genetic diversity, resistance mechanisms, and treatment outcomes have not been described at a national scale. In this study, we utilised whole-genome sequencing (WGS) in conjunction with routinely collected clinical data to characterise the population structure of circulating Mycobacterium tuberculosis (Mtb) strains, investigate transmission dynamics and assess treatment outcomes. Our findings indicate a high genetic diversity of Mtb strains in Botswana, with lineage 4 being the most prevalent. WGS analyses detected non-canonical rpoB mutations I491F and V170F, which are associated with low-level rifampicin resistance. Variants with these mutations are often missed by the routine molecular assays, which creates a risk of misclassification of cases. Phylogenetic analyses identified genomic clusters which suggest recent transmission within and across different health districts. These findings demonstrate the need for targeted interventions, such as intensified case finding and targeted contact tracing in identified hotspots, to help halt the transmission of RR-TB strains. Treatment success was high; however, mortality was higher among people living with HIV, which suggests the need for careful monitoring of this population. Notably, no variants resistant to new and repurposed drugs were detected in this study. In conclusion, this work demonstrates that RR-TB burden in Botswana is driven by genetically diverse Mtb strains and sustained by ongoing transmission. The detection of variants with mutations outside the rifampicin resistance-determining region highlights the existing diagnostic blind spot. Integrating next-generation sequencing (NGS) into surveillance, together with targeted public health interventions, careful stewardship of new and repurposed drugs, and implementing routine second-line drug susceptibility testing (DST) will protect the current gains, reduce mortality in high-risk populations, and accelerate progress towards the elimination of TB. Doctoral 2026-04-24T09:41:41Z 2026-04-24T09:41:41Z 2026-03 Thesis https://scholar.sun.ac.za/handle/10019.1/136183 en Stellenbosch University 202 pages application/pdf Stellenbosch : Stellenbosch University |
| spellingShingle | Mogashoa, Tuelo Rifampicin-resistant Mycobacterium tuberculosis: an emerging threat to human health in Botswana |
| title | Rifampicin-resistant Mycobacterium tuberculosis: an emerging threat to human health in Botswana |
| title_full | Rifampicin-resistant Mycobacterium tuberculosis: an emerging threat to human health in Botswana |
| title_fullStr | Rifampicin-resistant Mycobacterium tuberculosis: an emerging threat to human health in Botswana |
| title_full_unstemmed | Rifampicin-resistant Mycobacterium tuberculosis: an emerging threat to human health in Botswana |
| title_short | Rifampicin-resistant Mycobacterium tuberculosis: an emerging threat to human health in Botswana |
| title_sort | rifampicin resistant mycobacterium tuberculosis an emerging threat to human health in botswana |
| url | https://scholar.sun.ac.za/handle/10019.1/136183 |
| work_keys_str_mv | AT mogashoatuelo rifampicinresistantmycobacteriumtuberculosisanemergingthreattohumanhealthinbotswana |